GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

Children taking GLP-1 medications for weight loss, prediabetes, or type 2 diabetes may face an important nutritional concern. A new study published in Childhood Obesity found that nearly one in six young patients (16.8%) were diagnosed with a nutritional deficiency during the first year after starting treatment.

Vitamin D deficiency was the most frequently identified problem, affecting 12.4% of children within one year of beginning GLP-1 therapy.

Nutrition Matters During Childhood Growth